Compile Data Set for Download or QSAR
maximum 50k data
Found 99 Enz. Inhib. hit(s) with all data for entry = 10201
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520039((R)-methyl 4-(2-chloro-4-fluorophenyl)-6-(((S)-2-(...)
Affinity DataEC50:  12.6nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520040((R)-methyl 4-(2-chloro-4-fluorophenyl)-6-(((S)-2-(...)
Affinity DataEC50:  16.8nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520041(3-(4-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5...)
Affinity DataEC50:  14.8nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520042((R)-methyl 4-(2-chloro-4-fluorophenyl)-6-(((S)-2-(...)
Affinity DataEC50:  4.20nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520043((R)-methyl 4-(2-chloro-4-fluorophenyl)-6-(((S)-2-(...)
Affinity DataEC50:  19.4nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520044((R)-methyl 4-(2-chloro-4-fluorophenyl)-6-(((S)-2-(...)
Affinity DataEC50:  29nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520045((R)-methyl 4-(2-chloro-4-fluorophenyl)-6-(((S)-2-(...)
Affinity DataEC50:  6.20nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520046((R)-methyl 4-(2-chloro-4-fluorophenyl)-6-(((S)-2-(...)
Affinity DataEC50:  6.5nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520047((4R)-methyl 4-(2-chloro-4-fluorophenyl)-6-(((8aS)-...)
Affinity DataEC50:  6.80nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520048((R)-methyl 4-(2-chloro-4-fluorophenyl)-6-(((S)-2-(...)
Affinity DataEC50:  12.4nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520049(US11142527, Example 110)
Affinity DataEC50:  30.5nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520050(US11142527, Example 111)
Affinity DataEC50:  7.5nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520051(US11142527, Example 112)
Affinity DataEC50:  15.4nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520052(US11142527, Example 113)
Affinity DataEC50:  23.9nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520053(US11142527, Example 114)
Affinity DataEC50:  27.7nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520054(US11142527, Example 115)
Affinity DataEC50:  17.2nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520055(US11142527, Example 116)
Affinity DataEC50:  19.9nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520056(US11142527, Example 117)
Affinity DataEC50:  18.8nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520057(US11142527, Example 118)
Affinity DataEC50:  8.90nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520058(US11142527, Example 119)
Affinity DataEC50:  15.6nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520059(US11142527, Example 120)
Affinity DataEC50:  25.5nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520060(US11142527, Example 121)
Affinity DataEC50:  36.4nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520061(4-(5-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  45.6nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520062(US11142527, Example 123)
Affinity DataEC50:  37.9nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520063(US11142527, Example 124)
Affinity DataEC50:  47.4nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520064(US11142527, Example 125)
Affinity DataEC50:  21nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520065(3-(4′-((S)-7-(((R)-6-(2-chloro-4-fluoropheny...)
Affinity DataEC50:  6.70nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520066(US11142527, Example 131)
Affinity DataEC50:  8.60nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520067(US11142527, Example 134)
Affinity DataEC50:  4nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520068(US11142527, Example 135)
Affinity DataEC50:  6.5nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520069(US11142527, Example 136)
Affinity DataEC50:  20.1nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520070(US11142527, Example 137)
Affinity DataEC50:  10nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520071(US11142527, Example 138)
Affinity DataEC50:  34nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520072(US11142527, Example 139)
Affinity DataEC50:  10.7nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM520073(US11142527, Example 140)
Affinity DataEC50:  18.3nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM519975(US11142527, Example 1)
Affinity DataEC50:  8.45nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM519976(US11142527, Example 2)
Affinity DataEC50:  10.4nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM519977(US11142527, Example 4)
Affinity DataEC50:  19.8nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM519978(US11142527, Example 6)
Affinity DataEC50:  14nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM519979(US11142527, Example 7)
Affinity DataEC50:  8.78nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM519980(US11142527, Example 10)
Affinity DataEC50:  19.9nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM519981(US11142527, Example 11)
Affinity DataEC50:  32.5nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM519982(US11142527, Example 12)
Affinity DataEC50:  13nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM519983(4-(3-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  22.1nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM519984(4-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  22.7nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM519985(4-(2-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  10.8nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM519986(3-((6-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(...)
Affinity DataEC50:  12nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM519987(2-(4-(2-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5...)
Affinity DataEC50:  6nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM519988(2-(4′-((S)-7-(((R)-6-(2-chloro-4-fluoropheny...)
Affinity DataEC50:  13nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM519989(2-(4-(6-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5...)
Affinity DataEC50:  14nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 99 total ) | Next | Last >>
Jump to: